NICXF
Price
$0.25
Change
-$0.03 (-10.71%)
Updated
Mar 24 closing price
Capitalization
18.05M
TGTX
Price
$36.72
Change
-$1.23 (-3.24%)
Updated
Jun 27 closing price
Capitalization
5.83B
36 days until earnings call
Interact to see
Advertisement

NICXF vs TGTX

Header iconNICXF vs TGTX Comparison
Open Charts NICXF vs TGTXBanner chart's image
Nicox S.A
Price$0.25
Change-$0.03 (-10.71%)
Volume$500
Capitalization18.05M
TG Therapeutics
Price$36.72
Change-$1.23 (-3.24%)
Volume$2.47M
Capitalization5.83B
NICXF vs TGTX Comparison Chart in %
Loading...
NICXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NICXF vs. TGTX commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NICXF is a Hold and TGTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (NICXF: $0.25 vs. TGTX: $36.72)
Brand notoriety: NICXF and TGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NICXF: 100% vs. TGTX: 107%
Market capitalization -- NICXF: $18.05M vs. TGTX: $5.83B
NICXF [@Biotechnology] is valued at $18.05M. TGTX’s [@Biotechnology] market capitalization is $5.83B. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NICXF’s FA Score shows that 0 FA rating(s) are green whileTGTX’s FA Score has 1 green FA rating(s).

  • NICXF’s FA Score: 0 green, 5 red.
  • TGTX’s FA Score: 1 green, 4 red.
According to our system of comparison, TGTX is a better buy in the long-term than NICXF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NICXF’s TA Score shows that 2 TA indicator(s) are bullish while TGTX’s TA Score has 4 bullish TA indicator(s).

  • NICXF’s TA Score: 2 bullish, 0 bearish.
  • TGTX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, NICXF is a better buy in the short-term than TGTX.

Price Growth

NICXF (@Biotechnology) experienced а 0.00% price change this week, while TGTX (@Biotechnology) price change was +1.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

TGTX is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TGTX($5.83B) has a higher market cap than NICXF($18M). TGTX YTD gains are higher at: 21.993 vs. NICXF (4.167).
NICXFTGTXNICXF / TGTX
Capitalization18M5.83B0%
EBITDAN/A70.5M-
Gain YTD4.16721.99319%
P/E RatioN/A146.88-
RevenueN/A386M-
Total CashN/A132M-
Total DebtN/A8.98M-
FUNDAMENTALS RATINGS
NICXF vs TGTX: Fundamental Ratings
NICXF
TGTX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
89
Overvalued
PROFIT vs RISK RATING
1..100
10070
SMR RATING
1..100
9846
PRICE GROWTH RATING
1..100
6143
P/E GROWTH RATING
1..100
926
SEASONALITY SCORE
1..100
3050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TGTX's Valuation (89) in the Biotechnology industry is in the same range as NICXF (93) in the null industry. This means that TGTX’s stock grew similarly to NICXF’s over the last 12 months.

TGTX's Profit vs Risk Rating (70) in the Biotechnology industry is in the same range as NICXF (100) in the null industry. This means that TGTX’s stock grew similarly to NICXF’s over the last 12 months.

TGTX's SMR Rating (46) in the Biotechnology industry is somewhat better than the same rating for NICXF (98) in the null industry. This means that TGTX’s stock grew somewhat faster than NICXF’s over the last 12 months.

TGTX's Price Growth Rating (43) in the Biotechnology industry is in the same range as NICXF (61) in the null industry. This means that TGTX’s stock grew similarly to NICXF’s over the last 12 months.

TGTX's P/E Growth Rating (6) in the Biotechnology industry is significantly better than the same rating for NICXF (92) in the null industry. This means that TGTX’s stock grew significantly faster than NICXF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NICXFTGTX
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
85%
Stochastic
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
81%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
10%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
8%
Bullish Trend 3 days ago
83%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
84%
Declines
ODDS (%)
N/A
Bearish Trend 13 days ago
86%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
80%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
NICXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ABIYX17.840.16
+0.90%
AB International Value Advisor
RNPBX64.580.42
+0.65%
American Funds New Perspective R2
FEQAX13.820.06
+0.44%
Fidelity Advisor Hedged Equity Fund A
PSOPX26.500.04
+0.15%
JPMorgan Small Cap Value I
AAAVX12.12-0.02
-0.16%
DWS RREEF Real Assets R6

NICXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, NICXF has been loosely correlated with MDXXF. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if NICXF jumps, then MDXXF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NICXF
1D Price
Change %
NICXF100%
N/A
MDXXF - NICXF
45%
Loosely correlated
+7.07%
DNTH - NICXF
25%
Poorly correlated
-2.76%
TGTX - NICXF
24%
Poorly correlated
-3.24%
CYTK - NICXF
22%
Poorly correlated
-2.21%
CLVLF - NICXF
22%
Poorly correlated
N/A
More

TGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TGTX has been loosely correlated with ALT. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TGTX jumps, then ALT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TGTX
1D Price
Change %
TGTX100%
-3.24%
ALT - TGTX
40%
Loosely correlated
-54.60%
ROIV - TGTX
36%
Loosely correlated
-1.81%
CLLS - TGTX
36%
Loosely correlated
-2.54%
AVXL - TGTX
34%
Loosely correlated
-0.94%
KYMR - TGTX
34%
Loosely correlated
-3.48%
More